Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-02 · accession 0001437749-22-028592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-06 | 2022-12-02 | LMAT | Roberts David B | Pres, Dir | F - Tax | $47.17 | -102 | 14.6K | -0.7% | -$4,811 |
| D | 2022-12-06 | 2022-12-02 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | +4 | 14.8K | +0.0% | $0 |
| D | 2022-12-06 | 2022-12-02 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -4 | 19.59 | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-02 | F | D | 102 | $47.17 | 14,649 | D | — | — | (F2) These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/2/2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. |
| 2 | Common | Common Stock | 2022-12-02 | M | A | 4 | $0.00 | 14,751 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 3 | Derivative | Dividend Equivalent Rights | 2022-12-02 | M | D | 4 | $0.00 | 19.59 | D | $0.00 · — to — | 4 Common Stock | (F3) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/2/2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |